On May 28, 2025, the Company's stockholders approved the 2025 Plan, which has the objective of attracting and retaining skilled personnel and to enable the Company to grant equity compensation awards and other types of incentive compensation. As of June 30, 2026, there were 4.6 million shares of Common Stock available for issuance under the 2025 Plan.

The 2015 Plan, which was adopted on April 30, 2015 and expired in 2025, had the objective of attracting and retaining skilled personnel and enabled the Company to grant equity compensation awards and other types of incentive compensation. As of June 30, 2026, there were 0.9 million unvested awards under the 2015 Plan and certain vested but unexercised awards remained outstanding. No further awards can be granted under the 2015 Plan.


	Six Months Ended June 30,
	2026			2025
	RSUs/PSUs (000's)	Weighted Average Grant Date Fair Value		RSUs/PSUs (000's)	Weighted Average Grant Date Fair Value
Unvested at beginning of period	2,054	$	36.66	1,021	$	45.09
Granted	882	$	52.78	1,235	$	28.17
Vested	(550)	$	35.20	(308)	$	41.78
Forfeited and cancelled	(237)	$	39.95	(54)	$	40.21
Unvested at end of period	2,149	$	43.29	1,894	$	34.72

Grant Date

Number of

Shares (000's)

Performance Period

Metrics

Grant Date Fair Value

February 27, 2026

2026-2028

Revenue
rTSR

Revenue - $53.61

rTSR - $81.38

March 2, 2026

2026-2028

Revenue
rTSR

Revenue - $49.25

rTSR - $72.33

In November 2025, the Board approved a share repurchase program under which the Company may repurchase up to $300.0 million of its outstanding Common Stock. Share repurchases may be made from time to time through open market transactions, privately negotiated transactions and accelerated share repurchase transactions, arrangements or other methods, including transactions executed pursuant to a pre-set trading arrangement intended to satisfy the requirements of Rule 10b5-1(c) of the Exchange Act. As of June 30, 2026, $135.9 million remained available for repurchase under the program. The program does not obligate the Company to repurchase any shares, has no expiration date and may be modified, suspended, or terminated by the Board at any time at its discretion.

During the three and six months ended June 30, 2026, the Company repurchased approximately 3.3 million and 4.0 million shares of Common Stock, respectively, at a weighted average price of $30.55 and $31.38 per share, respectively. The total cost to repurchase these shares, including excise tax and commissions, for the three and six months ended June 30, 2026 was $101.4 million and $125.5 million, respectively. There were no share repurchases under a share repurchase program during either the three or six months ended June 30, 2025. As of June 30, 2026, none of the repurchased shares had been reissued.

To satisfy employees’ tax withholding obligations, the Company uses net settlement, under which shares of Common Stock are withheld upon vesting and the related taxes are paid by the Company in cash. For the three and six months ended June 30, 2026, $1.0 million and $9.8 million, respectively, were recorded for these net settlements. For the three and six months ended June 30, 2025, $0.9 million and $2.8 million, respectively were recorded for these net settlements. These amounts are reflected within the Repurchase of Common Stock line in the Condensed Consolidated Statements of Changes in Stockholders’ Equity and Mezzanine Equity and in the Condensed Consolidated Statements of Cash Flows.

In February 2025, the Board approved the Company’s 2025 ESPP, which authorized the issuance of up to 850,000 shares of Common Stock. The ESPP is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code. Eligible employees may elect to participate in the ESPP through payroll deductions of up to 15% during designated six-month offering periods. The first offering period commenced in January 2026 and concluded in June 2026. On each purchase date, accumulated payroll deductions will be used to purchase shares at a price equal to 85% of the lower of the Company's stock price on the applicable offering period start date or on the purchase date. Participants may withdraw from the ESPP in accordance with the plan’s terms and receive a refund of accumulated contributions that have not yet been used to purchase shares. The fair value of the discount associated with shares purchased under the plan is recognized as stock-based compensation expense over the offering period. Forfeitures are recognized as they occur.

During the six months ended June 30, 2026, employees purchased 29,298 shares of Common Stock. As of June 30, 2026, there were 820,702 shares available for issuance under the ESPP. There were no employee purchases during the comparable prior-year period, as the ESPP commenced in January 2026.